Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q2 2025 · 10-Q
Revenue$607.49K$607.49K−20.5% vs Q2 2024 Net Income-$2.25M-$2.25MN/M vs Q2 2024 EPS Diluted-$4.96-$4.96N/M vs Q2 2024 Gross Profit$223,113+12.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,324,752N/M Margins · derivedGross margin36.7%+10.6 pt vs Q2 2024
Operating margin-372.8%−112.1 pt vs Q2 2024
Net margin-370.3%−112.5 pt vs Q2 2024
ended Dec 31, 2024 · filed Feb 13, 2025 · 44 d after period end